American Healthcare REIT (NYSE:AHR) Issues FY 2025 Earnings Guidance

American Healthcare REIT (NYSE:AHR) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 1.690-1.72 for the period, compared to the consensus EPS estimate of 0.890. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on AHR. Royal Bank Of Canada lifted their target price on American Healthcare REIT from $39.00 to $45.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. UBS Group began coverage on American Healthcare REIT in a research report on Friday, September 19th. They set a “buy” rating and a $51.00 target price for the company. Zacks Research raised American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 17th. Robert W. Baird began coverage on American Healthcare REIT in a research report on Friday, July 18th. They set an “outperform” rating and a $41.00 target price for the company. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of American Healthcare REIT in a research report on Wednesday, September 3rd. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $45.00.

American Healthcare REIT Stock Up 1.7%

Shares of NYSE:AHR traded up $0.78 on Thursday, reaching $47.87. The company had a trading volume of 2,406,401 shares, compared to its average volume of 1,593,513. American Healthcare REIT has a 52-week low of $25.25 and a 52-week high of $48.21. The firm’s 50 day simple moving average is $42.72 and its 200-day simple moving average is $38.58. The firm has a market capitalization of $8.07 billion, a PE ratio of -217.61, a PEG ratio of 2.29 and a beta of 0.98. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The business had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. During the same period last year, the business posted $0.33 EPS. The business’s revenue was up 7.5% compared to the same quarter last year. As a group, analysts expect that American Healthcare REIT will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were issued a $0.25 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.1%. American Healthcare REIT’s dividend payout ratio (DPR) is currently -454.55%.

Insider Activity

In other news, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the transaction, the executive vice president directly owned 59,100 shares in the company, valued at approximately $2,475,699. This trade represents a 6.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.92% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. State of Wyoming purchased a new position in shares of American Healthcare REIT in the 2nd quarter valued at $61,000. Geneos Wealth Management Inc. grew its stake in American Healthcare REIT by 35.2% during the 2nd quarter. Geneos Wealth Management Inc. now owns 31,583 shares of the company’s stock worth $1,160,000 after buying an additional 8,218 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its stake in American Healthcare REIT by 13.8% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 249,935 shares of the company’s stock worth $9,188,000 after buying an additional 30,224 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in American Healthcare REIT by 454.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 22,989 shares of the company’s stock worth $845,000 after buying an additional 18,842 shares during the last quarter. Finally, Corient Private Wealth LLC grew its stake in American Healthcare REIT by 10.9% during the 2nd quarter. Corient Private Wealth LLC now owns 8,909 shares of the company’s stock worth $327,000 after buying an additional 876 shares during the last quarter. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.